Eurus Therapeutics develops a novel genome editing technology independent of CRISPR/Cas, by which Eurus is developing new therapies for genetic diseases.
What I expect of LINK-J
Continue developing as a holy place for life science entrepreneurs.
Message to LINK-J Special Members
Actively and openly join the LINK-J community.